Condition: Resistant Hypertension · Sponsor: DeepQure Inc.
HQ-HTN-K01-02 is a prospective, multicenter, single arm, open label, first-in-human study to evaluate the safety and initial efficacy of HyperQureTM, laparoscopic denervation therapy, in patients with resistant hypertension on 3 or more antihypertensive medications
This description comes directly from the study's public registry record.
Aeyoung Woo · 82-10-7109-0205 · aywoo@deepqure.com
Always discuss trial participation with your own doctor first.
| Chonnam National University Hospital Hwasun Hospital | Jeonam, Chonnam Province, South Korea | Recruiting |
| Seoul National University Bundang Hospital | Gyeonggi-do, South Korea | Recruiting |
| Asan Medical Center | Seoul, South Korea | Recruiting |
| Hanyang University Seoul Hospital | Seoul, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| The Catholic University of Korea, Seoul St. Mary's Hospital | Seoul, South Korea | Recruiting |
| Yonsei University Health System, Severance Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06216808